This, in turn, resulted in the downregulation of p53, cyclin-dependent kinase inhibitor 1a (CDKN1A), and mouse double minute 2 (mdm2) [78], ultimately contributing to the delayed progression of leukemia. The gene discussed is CDKN1A; the disease is leukemia.